SPC
FOLD

Sigma Planning Corp’s Amicus Therapeutics FOLD Stock Holding History

Sigma Planning Corp’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-61,765
Closed -$874K – 702
2015
Q2 		$874K Buy
61,765
+21,763
+54% +$262K 0.12% 207
2015
Q1 		$435K Sell
40,002
-4,073
-9% -$35.9K 0.06% 387
2014
Q4 		$367K Buy
+44,075
New +$303K 0.05% 427

Other funds holding FOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Sigma Planning Corp's FOLD Position: Q3 2015 in Review

Sigma Planning Corp sold out of Amicus Therapeutics (FOLD) in Q3 2015, closing a stake of 61,765 shares — an estimated $874K sold.

Sigma Planning Corp first reported a position in FOLD in Q4 2014 and held it in 3 quarters. The position peaked at $874K in Q2 2015. 147 funds tracked by Wall St. Rank hold FOLD as of Q3 2015.

  • Sigma Planning Corp reported no remaining Amicus Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Sigma Planning Corp sold 61,765 Amicus Therapeutics shares in Q3 2015, an estimated $874K.
  • Sigma Planning Corp first reported a position in Amicus Therapeutics in Q4 2014 and held it in 3 quarters.
  • Sigma Planning Corp's Amicus Therapeutics position peaked at $874K in Q2 2015.
  • 147 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2015.

Based on Sigma Planning Corp's 13F filing for Q3 2015, filed 2 Nov 2015.